First, a marked reduction of neuronal nitric oxide synthase (nNOS), that has been identified as a member of the dystrophin-glycoprotein complex, is observed in dystrophinopathies [149,150]. The gene discussed is NOS1; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.